ABANDONED - AFTER INTER-PARTES DECISION
after inter
on 13 Mar 2012
Last Applicant/ Owned by
One Johnson & Johnson Plaza
New Brunswick
NJ
089337001
Serial Number
85264167 filed on 11th Mar 2011
Registration Number
N/A
Correspondent Address
Cheryl L. Foytlin
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
INIZAN
Human pharmaceuticals for the treatment of infectious-related disease, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, metabolic diseases, anti-viral diseases, oncologic diseases, respiratory diseases, ophthalmic diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases; Human pharm Read More
Classification Information
Class [005]
Pharmaceutical Products
Human pharmaceuticals for the treatment of infectious-related disease, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, metabolic diseases, anti-viral diseases, oncologic diseases, respiratory diseases, ophthalmic diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases; Human pharmaceuticals for use as hemostatic agents
Mark Details
Serial Number
No 85264167
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th Mar 2012 | ABANDONMENT - AFTER INTER PARTES DECISION |
| 13th Mar 2012 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION |
| 13th Mar 2012 | OPPOSITION TERMINATED NO. 999999 |
| 13th Mar 2012 | OPPOSITION DISMISSED NO. 999999 |
| 24th Jan 2012 | OPPOSITION INSTITUTED NO. 999999 |
| 22nd Aug 2011 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 26th Jul 2011 | PUBLISHED FOR OPPOSITION |
| 06th Jul 2011 | NOTICE OF PUBLICATION |
| 09th Jun 2011 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 09th Jun 2011 | ASSIGNED TO EXAMINER |